<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-168 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-168</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-168</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-7.html">extraction-schema-7</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <p><strong>Paper ID:</strong> paper-f991e5c136c1f9549c48b6cdadf3911daa3d4e24</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/f991e5c136c1f9549c48b6cdadf3911daa3d4e24" target="_blank">Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer.</a></p>
                <p><strong>Paper Venue:</strong> The journals of gerontology. Series A, Biological sciences and medical sciences</p>
                <p><strong>Paper TL;DR:</strong> Differences in the susceptibility to cell death observed for lymphocytes from AD and skin cancer patients may be one of the mechanisms that help explain the inverse correlation detected between these diseases in epidemiological studies.</p>
                <p><strong>Cost:</strong> 0.011</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e168.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e168.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PBMC lymphocytes (AD)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Peripheral blood mononuclear cell lymphocytes from Alzheimer’s disease patients</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Human peripheral blood lymphocytes isolated from AD patients show increased vulnerability to oxidative stress in vitro, with a shift toward apoptotic death at lower H2O2 concentrations compared with controls.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Peripheral blood lymphocytes (PBMC-derived lymphocytes)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>In vitro exposure to H2O2 (10 μM–3 mM) for 20 hours produced a left-shifted dose–response for death in AD lymphocytes (LD50 23.7 ± 1.2 μM) vs healthy controls (LD50 35.6 ± 1.8 μM); AD cells showed significantly higher apoptosis at 20 and 50 μM H2O2 and greater total death at low concentrations.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Caspase-independent cell death that is substantially PARP-1-dependent (3-aminobenzamide reduced death), suggesting involvement of PARP-1-mediated mechanisms (parthanatos, NAD+ depletion, mitochondrial dysfunction/AIF-mediated nuclear effects); increased propensity toward apoptosis under oxidative stress.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human peripheral blood mononuclear cell lymphocytes isolated by Ficoll density centrifugation and exposed to H2O2 in vitro; viability/apoptosis/necrosis assessed by PI staining and flow cytometry; caspase activity measured with Caspase-Glo 3/7 assay; patients were clinically diagnosed AD (CDR 1–2).</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Mild-to-moderate Alzheimer’s disease (CDR 1–2)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>No direct contradictory findings reported in this paper; caspase inhibition had no effect (consistent with caspase-independence). PARP-1 inhibition protected cells in all groups but the protective effect tended to be smaller in AD lymphocytes (not statistically significant), and small sample sizes limit power.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer.", 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e168.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e168.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>PBMC lymphocytes (skin cancer donors)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Peripheral blood mononuclear cell lymphocytes from skin cancer survivors</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Human peripheral blood lymphocytes from patients with a history of skin cancer were relatively resistant to H2O2-induced death in vitro, showing reduced necrotic death compared with healthy controls and AD patients.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Peripheral blood lymphocytes (PBMC-derived lymphocytes) from skin cancer patients</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>resilient</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>In vitro H2O2 exposure produced a right-shifted dose–response for death in skin cancer lymphocytes (LD50 40.2 ± 3.2 μM) vs healthy controls; reduced necrosis at concentrations >50 μM (and lower necrosis than AD at 20 and 50 μM) was the main contributor to their increased resistance.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Lower necrotic response to oxidative stress; death was caspase-independent and PARP-1 inhibition reduced death in these cells as well, implicating PARP-1–linked pathways in the stress response but suggesting altered regulation favoring survival/less necrosis in cancer survivors' lymphocytes.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human peripheral blood mononuclear cell lymphocytes isolated and exposed to H2O2 in vitro; flow cytometry-based viability/apoptosis/necrosis measures; donors were patients with prior skin cancer (basal cell, squamous, or melanoma) and no cognitive impairment.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Not applicable to AD (cancer survivor group used for comparison); donors were cognitively normal (CDR 0)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>No contradictory data reported in this paper; authors note similar resistance observed in a small set of other cancer patients (prostate, breast, lung, colon) but numbers were insufficient for statistical analysis.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer.", 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e168.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e168.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Neurons</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Neurons (central nervous system neurons implicated in Alzheimer's disease)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Neurons are described as vulnerable in AD, with amyloid-beta and hyperphosphorylated tau deposits leading to synaptic dysfunction and neuronal death; PARP-1–linked mechanisms have been implicated in amyloid-induced neuronal death in cited studies.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Central nervous system neurons</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Introductory text and cited literature indicate widespread neuronal death in AD associated with beta-amyloid deposits and hyperphosphorylated tau; cited experimental work (Abeti et al.) reports amyloid-induced neuronal death in hippocampal/glial cocultures that is associated with PARP activation and prevented by PARP inhibitors.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Protein aggregation (beta-amyloid, tau) causing synaptic dysfunction and neuronal death; PARP-1 activation leading to PAR polymer accumulation, NAD+ depletion, mitochondrial dysfunction and parthanatos (AIF-mediated caspase-independent death) implicated in amyloid-mediated neuronal toxicity.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Mentioned via cited studies using neuronal/hippocampal and glial cocultures and prior literature on AD neuropathology (not directly studied in this paper).</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>General Alzheimer’s disease neurodegeneration (unspecified stages in the cited literature)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>This paper does not present contradictory findings; it notes PARP inhibitors prevent amyloid-induced neuronal death in cited work. Broader literature heterogeneity is not discussed here.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer.", 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e168.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e168.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Astrocytes</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Astrocytes (glial cells)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Astrocytes are implicated as vulnerable to amyloid-beta–induced metabolic failure via PARP-1 activation in cited studies, contributing to neuronal death in AD models.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Astrocytes (glial cells)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Cited work reports accumulation of poly(ADP-ribose) polymers, decreased NAD levels, and loss of mitochondrial membrane potential in astrocytes exposed to beta-amyloid; these alterations correlated with metabolic failure and were prevented by PARP inhibitors.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>PARP-1 overactivation in response to amyloid-induced DNA/oxidative damage leading to PAR polymer accumulation, NAD+ depletion, mitochondrial dysfunction and resultant astrocytic metabolic failure (contributing to parthanatos-like cell death pathways).</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Described in cited hippocampal/glial coculture experiments (not directly measured in the present study).</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Unspecified (experimental models of amyloid exposure relevant to AD pathology)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>No contradictory findings reported in this paper; role of astrocytic PARP-1 activation is presented as supportive evidence for PARP involvement in AD-related cell death.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer.", 'publication_date_yy_mm': '2012-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. <em>(Rating: 2)</em></li>
                <li>Age-dependent increases in apoptosis/necrosis ratios in human lymphocytes exposed to oxidative stress. <em>(Rating: 2)</em></li>
                <li>Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). <em>(Rating: 2)</em></li>
                <li>Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer’s disease. <em>(Rating: 1)</em></li>
                <li>Alzheimer’s disease. <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>